JP6659075B2 - Capsule body and method for producing the same - Google Patents
Capsule body and method for producing the same Download PDFInfo
- Publication number
- JP6659075B2 JP6659075B2 JP2014265121A JP2014265121A JP6659075B2 JP 6659075 B2 JP6659075 B2 JP 6659075B2 JP 2014265121 A JP2014265121 A JP 2014265121A JP 2014265121 A JP2014265121 A JP 2014265121A JP 6659075 B2 JP6659075 B2 JP 6659075B2
- Authority
- JP
- Japan
- Prior art keywords
- water
- capsule
- solution containing
- soluble polymer
- alginate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002775 capsule Substances 0.000 title claims description 99
- 238000004519 manufacturing process Methods 0.000 title claims description 18
- 229920003169 water-soluble polymer Polymers 0.000 claims description 45
- 239000007864 aqueous solution Substances 0.000 claims description 37
- 235000010443 alginic acid Nutrition 0.000 claims description 33
- 229920000615 alginic acid Polymers 0.000 claims description 33
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 31
- 229940072056 alginate Drugs 0.000 claims description 31
- 239000012528 membrane Substances 0.000 claims description 21
- 159000000007 calcium salts Chemical class 0.000 claims description 18
- 229920000642 polymer Polymers 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 16
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 14
- 239000000648 calcium alginate Substances 0.000 claims description 13
- 235000010410 calcium alginate Nutrition 0.000 claims description 13
- 229960002681 calcium alginate Drugs 0.000 claims description 13
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 13
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 12
- 239000002131 composite material Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 239000008384 inner phase Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 8
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 8
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 8
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 6
- 239000012071 phase Substances 0.000 description 22
- 239000002537 cosmetic Substances 0.000 description 17
- 239000003205 fragrance Substances 0.000 description 12
- 235000013305 food Nutrition 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 229920002125 Sokalan® Polymers 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229920000800 acrylic rubber Polymers 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- NZGKLLOWEPXNDG-SSCMEWPNSA-N (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-2,4a,6a,6b,9,9,12a-heptamethyl-10-octadecanoyloxy-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1(C)C NZGKLLOWEPXNDG-SSCMEWPNSA-N 0.000 description 1
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- DCAYPVUWAIABOU-UHFFFAOYSA-N alpha-n-hexadecene Natural products CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 238000007542 hardness measurement Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- -1 polysaccharide alginic acid Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011158 quantitative evaluation Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Landscapes
- Manufacturing Of Micro-Capsules (AREA)
- General Preparation And Processing Of Foods (AREA)
- Jellies, Jams, And Syrups (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Description
本発明は、化粧料や食品へ適用し得るカプセル体に関する。 The present invention relates to a capsule body applicable to cosmetics and foods.
近年、カプセル化技術が進み、化粧料や食品の分野において小さな球状のカプセル体が利用されている。これは、カプセル体の内相に有効成分等を安定に保持させることができたり、人工魚卵等の模倣食品に適したりするからである。
従来、多糖類であるアルギン酸を多価イオンで架橋したアルギン酸カルシウムやアルギン酸バリウムのカプセル体がよく利用されている(特許文献1等)。
カプセル体には、製造過程において任意の成分を内包させることができ、内相にエマルションや油分を含有させることも提案されている(特許文献2等)。これらの内相物の保持や、カプセル体の形状維持のために、カプセル体の保存外液を工夫することも提案されている(特許文献3)。
In recent years, encapsulation technology has advanced, and small spherical capsules have been used in the fields of cosmetics and foods. This is because the active ingredient and the like can be stably held in the inner phase of the capsule body, and it is suitable for imitation foods such as artificial fish eggs.
Conventionally, capsules of calcium alginate or barium alginate obtained by cross-linking polysaccharide alginic acid with polyvalent ions are often used (Patent Document 1 and the like).
It has been proposed that an arbitrary component can be included in the capsule body during the production process, and that the emulsion or oil component is contained in the internal phase (Patent Document 2 and the like). It has also been proposed to devise an external storage solution of the capsule body in order to retain these internal phase substances and maintain the shape of the capsule body (Patent Document 3).
化粧料や食品に適用されるカプセル体は、保存時や流通時に内相物を保持するだけでなく、使用時につぶして内相物を放出させることができる点にも特徴がある。例えば、化粧品においては有効成分を任意に放出させて肌に適用したり、食品においては人工魚卵と同様に噛つぶして味や食感を楽しんだりすることができる。
従来のアルギン酸カルシウムを膜の主成分とするカプセル体においては、膜厚を小さくすることによってカプセル体のつぶしやすさを実現していた。
Capsules applied to cosmetics and foods are characterized in that they not only retain the internal phase during storage or distribution, but also can be crushed and released during use. For example, in cosmetics, the active ingredient can be arbitrarily released and applied to the skin, and in food, the taste and texture can be enjoyed by chewing like an artificial fish egg.
In a conventional capsule body containing calcium alginate as a main component of the film, the capsule body is easily crushed by reducing the film thickness.
しかしながら、膜厚を小さくするとカプセル体をつぶしやすくなる一方で、膜が脆くなり内相を保持し難くなったり、意図しないときに内相物が膜を透過して放出してしまったりするという問題がある。また、従来のカプセル体では、カプセル膜をつぶす際の感触にも改良の余地がある。
このような状況に鑑みて、本発明は、アルギン酸カルシウムを含むカプセル膜を有するカプセル体において、つぶしやすい硬さを有しながら、内相物の透過・放出を抑制できるカプセル体を提供することを課題とする。さらに、良好な感触でつぶせるカプセル体を提供することをも課題とする。
However, when the film thickness is reduced, the capsule body is easily crushed, but the film becomes brittle and it becomes difficult to retain the internal phase, or the internal phase material permeates and releases the membrane when unintended. There is. Further, in the conventional capsule body, there is room for improvement in the feel when the capsule membrane is crushed.
In view of such a situation, the present invention provides a capsule body having a capsule membrane containing calcium alginate, which has a hardness that can be easily crushed and that can suppress permeation and release of an internal phase substance. Make it an issue. It is another object of the present invention to provide a capsule body that can be crushed with a good feel.
本発明者らは上記課題を解決するために鋭意研究を行った結果、アルギン酸カルシウムを含むカプセル外膜の構成に水溶性ポリマーを加えることにより、カプセル膜がつぶしやすい硬さを備えながら、内相物の透過・放出を抑制できることを見出し、本発明を完成するに至った。 The present inventors have conducted intensive studies in order to solve the above-mentioned problems, and as a result, by adding a water-soluble polymer to the composition of the capsule outer membrane containing calcium alginate, the capsule membrane has a hardness that allows the capsule membrane to be easily crushed while maintaining the internal phase. They have found that permeation and release of substances can be suppressed, and have completed the present invention.
すなわち、本発明は以下の通りである。
[1]カプセル外膜とカプセル内相とからなるカプセル体であって、
前記カプセル外膜はアルギン酸カルシウム及び水溶性ポリマーを含み、
前記カプセル内相は油性成分を含む、カプセル体(以降、「本発明のカプセル体」とも記す)。
[2]前記水溶性ポリマーが、ヒドロキシエチルセルロース、ポリビニルピロリドン、カルボキシビニルポリマー、PEG系ポリマー及びアクリル酸系ポリマーから選択される一種又は二種以上を含む、[1]に記載のカプセル体。
[3]前記カプセル外膜と前記カプセル内相との質量比が2:8〜9:1である、[1]又は[2]に記載のカプセル体。
[4]前記カプセル外膜におけるアルギン酸カルシウムと水溶性ポリマーとの質量比が1:0.1〜1:5である、[1]〜[3]の何れかに記載のカプセル体。
[5]カプセル体の製造方法であって、
アルギン酸塩及び水溶性ポリマーを含む水溶液と、カルシウム塩を含む水溶液とを接触させる工程を含む、製造方法(以降、「本発明の製造方法」とも記す)。
[6]さらに、油性成分を含む溶液の液滴を、アルギン酸塩及び水溶性ポリマーを含む水溶液の液膜で覆うことにより複合液滴を形成する工程を含み、
カルシウム塩を含む水溶液中に前記複合液滴を滴下することにより、アルギン酸塩及び水溶性ポリマーを含む水溶液と、カルシウム塩を含む水溶液とを接触させる工程を行う、[5]に記載の製造方法。
[7]前記水溶性ポリマーが、ヒドロキシエチルセルロース、ポリビニルピロリドン、カルボキシビニルポリマー、PEG系ポリマー及びアクリル酸系ポリマーから選択される一種又は二種以上を含む、[5]又は[6]に記載の製造方法。
[8]前記アルギン酸塩及び水溶性ポリマーを含む水溶液におけるアルギン酸塩と水溶性ポリマーとの質量比が1:0.1〜1:5である、[5]〜[7]の何れかに記載の製造方法。
[9]前記アルギン酸塩及び水溶性ポリマーを含む水溶液におけるアルギン酸塩の濃度が0.20〜2.50質量%である、[5]〜[8]の何れかに記載の製造方法。
[10]前記アルギン酸塩及び水溶性ポリマーを含む水溶液における水溶性ポリマーの濃度が0.1〜2.0質量%である、[5]〜[9]の何れかにに記載の製造方法。
[11]前記カルシウム塩を含む水溶液におけるカルシウム塩の濃度が2.0〜15質量%である、[5]〜[10]の何れかに記載の製造方法。
That is, the present invention is as follows.
[1] A capsule body comprising a capsule outer membrane and a capsule inner phase,
The capsule outer membrane includes calcium alginate and a water-soluble polymer,
The capsule internal phase is a capsule body containing an oily component (hereinafter, also referred to as “capsule body of the present invention”).
[2] The capsule according to [1], wherein the water-soluble polymer includes one or more selected from hydroxyethylcellulose, polyvinylpyrrolidone, carboxyvinyl polymer, PEG-based polymer, and acrylic acid-based polymer.
[3] The capsule body according to [1] or [2], wherein the mass ratio between the capsule outer membrane and the capsule inner phase is 2: 8 to 9: 1.
[4] The capsule body according to any one of [1] to [3], wherein the mass ratio of calcium alginate and water-soluble polymer in the capsule outer membrane is 1: 0.1 to 1: 5.
[5] A method for producing a capsule body,
A production method including a step of contacting an aqueous solution containing an alginate and a water-soluble polymer with an aqueous solution containing a calcium salt (hereinafter, also referred to as “the production method of the present invention”).
[6] The method further includes forming a composite droplet by covering the droplet of the solution containing the oily component with a liquid film of an aqueous solution containing an alginate and a water-soluble polymer,
The production method according to [5], wherein a step of contacting an aqueous solution containing an alginate and a water-soluble polymer with an aqueous solution containing a calcium salt is performed by dropping the composite droplet into an aqueous solution containing a calcium salt.
[7] The production according to [5] or [6], wherein the water-soluble polymer includes one or more selected from hydroxyethylcellulose, polyvinylpyrrolidone, carboxyvinyl polymer, PEG-based polymer, and acrylic acid-based polymer. Method.
[8] The method according to any one of [5] to [7], wherein the mass ratio of the alginate and the water-soluble polymer in the aqueous solution containing the alginate and the water-soluble polymer is 1: 0.1 to 1: 5. Production method.
[9] The production method according to any one of [5] to [8], wherein the concentration of the alginate in the aqueous solution containing the alginate and the water-soluble polymer is 0.20 to 2.50% by mass.
[10] The production method according to any one of [5] to [9], wherein the concentration of the water-soluble polymer in the aqueous solution containing the alginate and the water-soluble polymer is 0.1 to 2.0% by mass.
[11] The method according to any one of [5] to [10], wherein the concentration of the calcium salt in the aqueous solution containing the calcium salt is 2.0 to 15% by mass.
本発明により、つぶしやすい硬さを有しながら、内相物の透過・放出を抑制でき、さらにつぶす際の感触が良好なカプセル体が提供される。
これにより、本発明のカプセル体を化粧料に適用した場合の使用感や、食品に適用した場合の食感が優れたものとなる。
また、本発明のカプセル体により、内相に含む油性成分の透過を抑制したり、油性成分中に香料等の香り放出成分を含む場合に香りを徐放したりすることができる。したがって、本発明のカプセル体を化粧料に適用した場合に、有効成分の品質を維持したり、香りを長続きさせたりすることもできる。
ADVANTAGE OF THE INVENTION According to this invention, while having the hardness which is easy to crush, the permeation and discharge | release of an internal phase substance can be suppressed, and also the capsule body with a good feeling at the time of crushing is provided.
Thereby, the feeling of use when the capsule body of the present invention is applied to cosmetics and the texture when applied to foods are excellent.
Further, the capsule of the present invention can suppress permeation of an oily component contained in the internal phase, or can gradually release a scent when a scent releasing component such as a fragrance is contained in the oily component. Therefore, when the capsule body of the present invention is applied to a cosmetic, the quality of the active ingredient can be maintained and the fragrance can be maintained for a long time.
<本発明のカプセル体>
本発明のカプセル体は、カプセル外膜とカプセル内相とからなるカプセル体であって、前記カプセル外膜はアルギン酸カルシウム及び水溶性ポリマーを含み、前記カプセル内相は油性成分を含む。
<Capsule of the present invention>
The capsule body of the present invention is a capsule body comprising a capsule outer membrane and a capsule inner phase, wherein the capsule outer membrane contains calcium alginate and a water-soluble polymer, and the capsule inner phase contains an oil component.
本明細書における水溶性ポリマーは、室温において蒸留水に0.1質量%以上溶解するポリマーであれば特に限定されない。
前記水溶性ポリマーは、ヒドロキシエチルセルロース、ポリビニルピロリドン、カルボキシビニルポリマー、PEG系ポリマー、アクリル酸系ポリマー等を一種又は任意の組み
合わせで二種以上含むことができる。PEG系ポリマーとしては例えば(PEG−240/デシルテトラデセス−20/HDI)コポリマー等を、アクリル酸系ポリマーとしては例えば(アクリル酸/アクリル酸アルキル(C10−30))コポリマー、アクリル酸/アクリル酸アルキル/VA)コポリマー、アクリル酸アルキルコポリマーアンモニウム等を挙げられる。これらのうち、特にヒドロキシエチルセルロースがよりつぶしやすい硬さを得られるため好ましい。
水溶性ポリマーは、特に限定されないが、重量平均分子量が10万〜1000万であることが好ましく、500〜500万であることがより好ましく、100〜200万であることがさらに好ましい。
The water-soluble polymer in the present specification is not particularly limited as long as it is a polymer that dissolves in distilled water at room temperature at 0.1% by mass or more.
The water-soluble polymer may include two or more kinds of hydroxyethyl cellulose, polyvinylpyrrolidone, carboxyvinyl polymer, PEG-based polymer, acrylic acid-based polymer, or the like in one kind or in an arbitrary combination. Examples of the PEG-based polymer include (PEG-240 / decyltetradeceth-20 / HDI) copolymer, and examples of the acrylic acid-based polymer include (acrylic acid / alkyl acrylate (C10-30)) copolymer and acrylic acid / acrylic. Alkyl / VA) copolymers, alkyl acrylate copolymer ammonium and the like. Of these, hydroxyethylcellulose is particularly preferred because it can provide a more easily crushable hardness.
The water-soluble polymer is not particularly limited, but preferably has a weight average molecular weight of 100,000 to 10,000,000, more preferably 5 to 5,000,000, and further preferably 1 to 2,000,000.
カプセル内相は、通常、液状(室温、1気圧下)である。また、カプセル内相の油性成分とは、いわゆる油剤に限らず、室温においてワセリンに相溶性のある成分であればよい。
後述するように本発明のカプセル体を化粧料に適用する場合の油性成分としては、通常化粧料に用いる油剤である極性油、天然油、炭化水素油、シリコーン油等、例えば、ジメチコン、エチルヘキサン酸セチル、ミネラルオイル等が好ましく挙げられる。
また、油溶性の各種有効成分、例えば美白成分、抗炎症成分、ビタミン類等や、油溶性の香料等を油性成分として内相に含有させることが好ましい。美白成分としてはレゾルシノール類、各種植物抽出物等を、抗炎症成分としてはグリチルレチン酸ステアリル、ステアリン酸グリチルレチニル等を、ビタミン類としてはビタミンA、ビタミンE等を、油溶性の香料としては炭化水素系、アルデヒド系、アルコール系、フェノール系、アセタール系、ケトン系、エーテル系、合成ムスク、ラクトン類、酸類、エステル系等のものを、例示できる。
The internal phase of the capsule is usually liquid (at room temperature and under 1 atm). The oil component in the capsule inner phase is not limited to a so-called oil agent, but may be any component that is compatible with petrolatum at room temperature.
As described below, when the capsule body of the present invention is applied to cosmetics, the oily component includes polar oils, natural oils, hydrocarbon oils, silicone oils and the like which are usually used in cosmetics, such as dimethicone and ethyl hexane. Cetyl acid and mineral oil are preferred.
Further, it is preferable to include various oil-soluble active ingredients, for example, a whitening component, an anti-inflammatory component, vitamins, and the like, and an oil-soluble flavor as an oil component in the internal phase. Resorcinols and various plant extracts as whitening ingredients, stearyl glycyrrhetinate and glycyrrhetinyl stearate as anti-inflammatory ingredients, vitamins A and E as vitamins, and hydrocarbon-based fragrances as oil-soluble flavors Aldehyde-based, alcohol-based, phenol-based, acetal-based, ketone-based, ether-based, synthetic musk, lactones, acids, esters, and the like.
本発明のカプセル体において、カプセル外膜と前記カプセル内相との質量比は、2:8〜9:1であることが好ましく、3:7〜6:4であることがより好ましい。このような比率であることにより、カプセル体のつぶしやすい硬さを実現することができる。
また、本発明のカプセル体において、カプセル外膜におけるアルギン酸カルシウムと水溶性ポリマーとの質量比は、1:0.1〜1:5であることが好ましく、1:0.3〜1:2であることがより好ましく、1:0.4〜1:0.9であることがさらに好ましい。このような比率であることにより、カプセル体のつぶしやすい硬さを実現することができる。
In the capsule body of the present invention, the mass ratio of the capsule outer membrane to the capsule inner phase is preferably from 2: 8 to 9: 1, and more preferably from 3: 7 to 6: 4. With such a ratio, the hardness of the capsule body that can be easily crushed can be realized.
In the capsule body of the present invention, the mass ratio of calcium alginate to the water-soluble polymer in the capsule outer membrane is preferably from 1: 0.1 to 1: 5, and preferably from 1: 0.3 to 1: 2. More preferably, the ratio is more preferably 1: 0.4 to 1: 0.9. With such a ratio, the hardness of the capsule body that can be easily crushed can be realized.
本発明のカプセル体は、通常、球状である。ここで球状とは、真球状に限られず、略球状や回転楕円体のもの等も含む。
本発明のカプセル体の粒径は、特に限定されないが、0.1〜50mmであることが好ましく、2〜8mmであることがより好ましく、3〜6mmであることがさらに好ましい。
The capsule of the present invention is usually spherical. Here, the term “spherical” is not limited to a true spherical shape, and includes a substantially spherical shape, a spheroidal shape, and the like.
The particle size of the capsule body of the present invention is not particularly limited, but is preferably from 0.1 to 50 mm, more preferably from 2 to 8 mm, and still more preferably from 3 to 6 mm.
本発明のカプセル体は、他に化粧料や食品が通常含有し得る成分を任意に含有することができる。 The capsule body of the present invention can optionally contain other components that can be normally contained in cosmetics and foods.
<本発明のカプセル体の製造方法>
本発明のカプセル体は、特に限定されるものではないが、アルギン酸塩及び水溶性ポリマーを含む水溶液と、カルシウム塩を含む水溶液とを接触させる工程を含む方法により製造することができる。かかる接触によりアルギン酸のカルシウムイオンによる架橋が開始し、アルギン酸カルシウムのゲル膜が形成される。ここで、本発明のカプセル体における油性成分は、任意の方法でアルギン酸カルシウムのカプセル膜内に包含させてよい。
上記製造方法の好ましい態様としては、さらに油性成分を含む溶液の液滴を、アルギン酸塩及び水溶性ポリマーを含む水溶液の液膜で覆うことにより複合液滴を形成する工程を
含む。かかる複合液滴の形成工程は、例えば、特開平5−317387号公報のように、アルギン酸塩及び水溶性ポリマーを含む水溶液の液滴の内側に油性成分を含む溶液の液滴を滴下することにより行うことができる。また、この態様においてアルギン酸塩及び水溶性ポリマーを含む水溶液と、カルシウム塩を含む水溶液とを接触させる工程は、カルシウム塩を含む水溶液中に前記複合液滴を滴下することによって行うことが好ましい。これにより、アルギン酸塩及び水溶性ポリマーを含む水溶液に油性成分を含む溶液が覆われたまま、両溶液が同時にカルシウム塩を含む水溶液に滴下することになる。
<Method for producing capsule body of the present invention>
Although not particularly limited, the capsule body of the present invention can be produced by a method including a step of contacting an aqueous solution containing an alginate and a water-soluble polymer with an aqueous solution containing a calcium salt. By such contact, crosslinking of alginic acid by calcium ions starts, and a gel film of calcium alginate is formed. Here, the oily component in the capsule body of the present invention may be included in the capsule membrane of calcium alginate by any method.
A preferred embodiment of the above production method further includes a step of forming a composite droplet by covering a droplet of a solution containing an oily component with a liquid film of an aqueous solution containing alginate and a water-soluble polymer. The step of forming such a composite droplet is performed by, for example, dropping a droplet of a solution containing an oil component inside a droplet of an aqueous solution containing an alginate and a water-soluble polymer, as disclosed in JP-A-5-31787. It can be carried out. In this embodiment, the step of bringing the aqueous solution containing the alginate and the water-soluble polymer into contact with the aqueous solution containing the calcium salt is preferably performed by dropping the composite droplet into the aqueous solution containing the calcium salt. As a result, both solutions are simultaneously dropped into the aqueous solution containing the calcium salt while the aqueous solution containing the alginate and the water-soluble polymer is covered with the solution containing the oily component.
前記水溶性ポリマーは、ヒドロキシエチルセルロース、ポリビニルピロリドン、カルボキシビニルポリマー、PEG系ポリマー、アクリル酸系ポリマー等を一種又は任意の組み合わせで二種以上含むことができる。PEG系ポリマーとしては例えば(PEG−240/デシルテトラデセス−20/HDI)コポリマー等を、アクリル酸系ポリマーとしては例えば(アクリル酸/アクリル酸アルキル(C10−30))コポリマー、アクリル酸/アクリル酸アルキル/VA)コポリマー、アクリル酸アルキルコポリマーアンモニウム等を挙げられる。これらのうち、特にヒドロキシエチルセルロースがよりつぶしやすい硬さを得られるため好ましい。
水溶性ポリマーは、特に限定されないが、分子量が10万〜1000万であることが好ましく、500〜500万であることがより好ましく、100〜200万であることがさらに好ましい。
The water-soluble polymer may include two or more kinds of hydroxyethyl cellulose, polyvinylpyrrolidone, carboxyvinyl polymer, PEG-based polymer, acrylic acid-based polymer, or the like in one kind or in an arbitrary combination. Examples of the PEG-based polymer include (PEG-240 / decyltetradeceth-20 / HDI) copolymer, and examples of the acrylic acid-based polymer include (acrylic acid / alkyl acrylate (C10-30)) copolymer and acrylic acid / acrylic. Alkyl / VA) copolymers, alkyl acrylate copolymer ammonium and the like. Of these, hydroxyethylcellulose is particularly preferred because it can provide a more easily crushable hardness.
The water-soluble polymer is not particularly limited, but preferably has a molecular weight of 100,000 to 10,000,000, more preferably 5 to 5,000,000, and further preferably 1 to 2,000,000.
アルギン酸塩及び水溶性ポリマーを含む水溶液において、アルギン酸塩は水溶性であれば特に限定されず、例えばアルギン酸ナトリウム、アルギン酸カリウム等のアルカリ金属塩類、アルギン酸トリエタノールアミン、アルギン酸アンモニウムなどのアミン塩類等を用いることができる。また、アルギン酸塩の重量平均分子量としては、例えば1万〜60万のものが好ましい。 In an aqueous solution containing an alginate and a water-soluble polymer, the alginate is not particularly limited as long as it is water-soluble. be able to. The weight average molecular weight of the alginate is preferably, for example, 10,000 to 600,000.
アルギン酸塩及び水溶性ポリマーを含む水溶液におけるアルギン酸塩と水溶性ポリマーとの質量比は、1:0.1〜1:5であることが好ましく、1:0.3〜1:2であることがより好ましく、1:0.4〜1:0.9であることがさらに好ましい。このような比率であることにより、つぶしやすい硬さを有するカプセル体を製造することができる。
また、前記水溶液におけるアルギン酸塩の濃度は、0.20〜2.50質量%が好ましく、0.5〜2.0質量%がより好ましく、1.0〜2.0質量%がさらに好ましい。
また、前記水溶液における水溶性ポリマーの濃度は、0.1〜2.0質量%が好ましく、0.5〜1.0質量%がより好ましい。
The mass ratio between the alginate and the water-soluble polymer in the aqueous solution containing the alginate and the water-soluble polymer is preferably from 1: 0.1 to 1: 5, and preferably from 1: 0.3 to 1: 2. More preferably, it is still more preferably 1: 0.4 to 1: 0.9. With such a ratio, it is possible to manufacture a capsule body having hardness that is easily crushed.
Further, the concentration of alginate in the aqueous solution is preferably 0.20 to 2.50% by mass, more preferably 0.5 to 2.0% by mass, and still more preferably 1.0 to 2.0% by mass.
The concentration of the water-soluble polymer in the aqueous solution is preferably 0.1 to 2.0% by mass, more preferably 0.5 to 1.0% by mass.
カルシウム塩を含む溶液において、カルシウム塩は水溶性であれば特に限定されず、例えば塩化カルシウム、硫酸カルシウム、クエン酸カルシウム、リン酸カルシウム等を用いることができる。
また、前記溶液におけるカルシウム塩の濃度は、2.0〜15質量%が好ましく、3〜10質量%がより好ましい。
In the solution containing the calcium salt, the calcium salt is not particularly limited as long as it is water-soluble, and for example, calcium chloride, calcium sulfate, calcium citrate, calcium phosphate and the like can be used.
Further, the concentration of the calcium salt in the solution is preferably 2.0 to 15% by mass, more preferably 3 to 10% by mass.
本発明の製造方法においては、前述の複合液滴を形成する、油性成分を含む溶液の液滴とアルギン酸塩及び水溶性ポリマーを含む水溶液の液膜との質量比を変えること、及び/又は複合液滴の滴下速度を変えることによって、内外相比やカプセル膜の厚さを任意に調節することができる。また、複合液滴の大きさを変えること、すなわち複合液滴中の上記各溶液の質量を変えることによって、カプセル体の粒径を任意に調節することができる。
油性成分を含む溶液の液滴やアルギン酸塩及び水溶性ポリマーを含む水溶液の液膜の質量の変更は、例えば、これらの溶液の液滴や液膜を形成する際に溶液を吐出する各ノズルの口径を変えることで達成できる。
本発明の製造方法は、2本のシリンジを用いて手動で行う他に、例えば油性成分を含む
溶液と、アルギン酸塩及び水溶性ポリマーを含む水溶液とをそれぞれ吐出するノズル、及びノズルから吐出された液滴を受けるためのカルシウム塩を含む水溶液を抱える水槽を備える装置により実行することができる。かかる装置としては、例えば一軸偏心ねじポンプが挙げられる。
In the production method of the present invention, changing the mass ratio between the droplet of the solution containing the oil component and the liquid film of the aqueous solution containing the alginate and the water-soluble polymer to form the above-mentioned composite droplet, and / or By changing the dropping speed of the droplet, the ratio between the internal and external phases and the thickness of the capsule film can be arbitrarily adjusted. Also, by changing the size of the composite droplet, that is, by changing the mass of each solution in the composite droplet, the particle size of the capsule can be arbitrarily adjusted.
Changing the mass of the liquid droplets of the solution containing the oily component or the liquid film of the aqueous solution containing the alginate and the water-soluble polymer can be performed, for example, by changing the nozzle of each nozzle that discharges the solution when forming the liquid droplets or the liquid film of these solutions. This can be achieved by changing the caliber.
The production method of the present invention is performed manually using two syringes, for example, a nozzle that discharges a solution containing an oily component and an aqueous solution containing an alginate and a water-soluble polymer, and the nozzle is discharged from the nozzle. It can be carried out by an apparatus provided with a water tank holding an aqueous solution containing a calcium salt for receiving droplets. An example of such a device is a single-shaft eccentric screw pump.
本発明のカプセル体は、つぶしやすい硬さを有しながら、内相物の透過・放出を抑制でき、さらにつぶす際の感触が良好である。そのため、内相に包含される成分を安定に維持することができ、劣化を防止することができる。また、適当な力でかつ感触良くつぶすことができる。具体的には、過度に力を入れずともつぶすことができ、かつ柔らかくつぶれてカプセル膜の残留感や異物感が残らずになじむので、化粧料に適用した場合の使用感や、食品に適用した場合の食感が優れたものとなる。
また、本発明のカプセル体は透明な球状であるため、美麗な外観を演出することもできる。
ADVANTAGE OF THE INVENTION The capsule body of this invention can suppress permeation and discharge | release of an internal phase substance, and has a good feeling at the time of crushing, while having hardness which is easy to crush. Therefore, the components included in the internal phase can be stably maintained, and deterioration can be prevented. Moreover, it can be crushed with an appropriate force and with a good touch. Specifically, it can be crushed without applying excessive force, and it is softly crushed and fits without leaving a feeling of residual or foreign substance on the capsule membrane. In this case, the texture becomes excellent.
Further, since the capsule body of the present invention has a transparent spherical shape, a beautiful appearance can be produced.
本発明のカプセル体は化粧料に好ましく適用でき、例えば美白成分、ビタミンA、ビタミンE等の油溶性の有効成分や香料等を内相に含有させて、ローション、クリーム、美容液、洗顔料、洗髪料等に配合することができる。特に、内相に香料を含有させた場合、カプセル膜が香りを透過させすぎないため、香りを徐放することができ、化粧料の香りを長続きさせることができる。
本発明のカプセル体を化粧料に含有させる場合、その態様は特に限定されないが、例えば水性のローションやジェル等の中にカプセル体を分散又は浸漬させて化粧料を構成する態様が、好ましく挙げられる。このような態様で提供される化粧料は、水性のローションやジェルによってカプセル膜が膨潤し、カプセル体がよりつぶれやすくなる。また、カプセル体をつぶすことで内相に包含される油溶成分が、化粧料使用時に水性のローションやジェルの相にフレッシュな状態で放出されることが叶う。
The capsule body of the present invention can be preferably applied to cosmetics. For example, a whitening ingredient, an oil-soluble active ingredient such as vitamin A or vitamin E, a fragrance and the like are contained in an internal phase, and a lotion, a cream, a serum, a face wash, It can be blended into hair washes and the like. In particular, when a fragrance is contained in the internal phase, the capsule film does not allow the fragrance to pass too much, so that the fragrance can be released gradually, and the fragrance of the cosmetic can be maintained for a long time.
When the capsule of the present invention is contained in a cosmetic, the aspect is not particularly limited. For example, an aspect in which the cosmetic is constituted by dispersing or immersing the capsule in an aqueous lotion, gel, or the like is preferably mentioned. . In the cosmetic provided in such an embodiment, the capsule membrane is swelled by the aqueous lotion or gel, and the capsule body is more easily crushed. Further, by crushing the capsule body, the oil-soluble component contained in the internal phase can be released in a fresh state into an aqueous lotion or gel phase when the cosmetic is used.
また、本発明のカプセル体は食品にも好ましく適用できる。アルギン酸カルシウムは食品としての安全性も確立しており、水溶性ポリマーとして例えばセルロース系ポリマーを用いた場合、人工魚卵等の模倣食品や、健康食品等のカプセル剤等に適用でき、かみつぶした場合の良好な食感が得られる。 Further, the capsule body of the present invention can be preferably applied to foods. Calcium alginate has also established its safety as a food.For example, when a cellulosic polymer is used as the water-soluble polymer, it can be applied to imitation foods such as artificial fish eggs and capsules of health foods, etc. In this case, good texture is obtained.
以下、本発明を実施例により更に詳細に説明するが、本発明は、その要旨を超えない限り、以下の実施例に限定されるものではない。 Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to the following examples unless it exceeds the gist.
下記表1の処方にしたがって、油性成分を内相に含むカプセル体を作製した。具体的には、一軸偏心ねじポンプを使用し、ホッパーに充填した成分イを滴下ノズル1(直径2mm)から、別のホッパーに重点した成分ロを滴下ノズル2(直径5mm)からそれぞれ吐出して、成分イが内側で成分ロが外側の二層の複合液滴を形成させた。該複合液滴を成分ハ(塩化カルシウム溶液)中に滴下した。また、実施例6では、架橋されたカプセル体を取り出し、十分に水洗いした後、水溶性または油溶性ジェル(ニ)に適量添加した。 According to the formulation of Table 1 below, a capsule body containing an oil component in the internal phase was prepared. Specifically, using a uniaxial eccentric screw pump, the component A filled in the hopper is discharged from the dripping nozzle 1 (diameter 2 mm), and the component B focused on another hopper is discharged from the dripping nozzle 2 (diameter 5 mm). A two-layered composite droplet was formed in which component a was inside and component b was outside. The composite droplet was dropped into component C (calcium chloride solution). In Example 6, the crosslinked capsule body was taken out, washed sufficiently with water, and then added to a water-soluble or oil-soluble gel (d) in an appropriate amount.
<試験例1> 香り放出の官能評価
3ccのエチルヘキサン酸セチルを充填した6ccバイアル瓶に、純水及びエチルヘキ
サン酸セチルで2度洗いした実施例又は比較例の各カプセル体10粒を入れ、20℃で2週間静置した。2週間後に瓶口にて香り立ち(放出)を下記の4段階で評価した(n=3)。結果を表1に示す。
評価条件;
◎・・・放出していない
○・・・ほとんど放出していない
△・・・やや放出している
×・・・明らかに放出している
<Test Example 1> Sensory evaluation of fragrance release In a 6 cc vial filled with 3 cc of cetyl ethyl hexanoate, 10 capsules of each of the examples or comparative examples washed twice with pure water and cetyl ethyl hexanoate were put. It was allowed to stand at 20 ° C. for 2 weeks. Two weeks later, the fragrance (release) was evaluated at the bottle mouth on the following four scales (n = 3). Table 1 shows the results.
Evaluation conditions;
◎ ・ ・ ・ Not released ○ ・ ・ ・ Almost not released △ ・ ・ ・ Slightly released × ・ ・ ・ Clearly released
<試験例2> 香り放出の定量評価
試験例1でカプセル体を2週間浸漬したエチルヘキサン酸溶液200μLをとり、試料溶液とした。別に、標準試薬0.5gを精密に量り取り、テトヒドロフランを加えて正確に50mLとして、1%の標準原液とした。標準原液をテトラヒドロフランで適宜希釈し、2000ppm、1000ppm、500ppm及び100ppmの標準溶液とした。
試料溶液、標準溶液それぞれについて、以下の条件でガスクロマトグラフィー(GC)/FID分析を行い、絶対検量線法によりリモネンの濃度を測定し、下記の4段階で評価した。結果を表1に示す。
≪GC測定条件≫
装置 :Agilent 7890GC
カラム :HP−5 0.25mmI.D.x30m,0.25μm
キャリアガス :ヘリウム
注入量 :1μL
評価条件;
◎・・・0〜200ppm
○・・・200〜400ppm
△・・・400〜800ppm
×・・・800ppm〜
<Test Example 2> Quantitative evaluation of fragrance release In Test Example 1, 200 μL of the ethylhexanoic acid solution in which the capsule was immersed for 2 weeks was used as a sample solution. Separately, 0.5 g of the standard reagent was precisely weighed out, and tetrahydrofuran was added to make exactly 50 mL, thereby obtaining a 1% standard stock solution. The standard stock solution was appropriately diluted with tetrahydrofuran to obtain standard solutions of 2000 ppm, 1000 ppm, 500 ppm and 100 ppm.
For each of the sample solution and the standard solution, gas chromatography (GC) / FID analysis was performed under the following conditions, and the limonene concentration was measured by the absolute calibration curve method, and evaluated by the following four steps. Table 1 shows the results.
<< GC measurement conditions >>
Apparatus: Agilent 7890GC
Column: HP-5 0.25 mm ID x 30 m, 0.25 μm
Carrier gas: Helium injection amount: 1 μL
Evaluation conditions;
◎ ・ ・ ・ 0 to 200ppm
○ ・ ・ ・ 200-400ppm
△ ・ ・ ・ 400-800ppm
× ・ ・ ・ 800ppm〜
<試験例3> カプセル体のつぶれやすさの官能評価
作製直後の実施例又は比較例の各カプセル体1粒を手の甲に置き、人差し指を軽く押し当て横にひずみを与えた時のつぶれやすさを、下記の4段階で評価した。結果を表1に示す。
評価条件;
◎・・・快くつぶれる
○・・・まあまあつぶれやすい
△・・・やや硬いがつぶれる
×・・・硬くつぶれない
<Test Example 3> Sensory Evaluation of Easiness of Crushing of Capsule Each capsule body of the example or the comparative example immediately after the preparation was placed on the back of the hand, and the index finger was lightly pressed to give a strain to the side, and the ease of crushing was measured. And the following four grades. Table 1 shows the results.
Evaluation conditions;
◎ ・ ・ ・ Pleasantly crushed ○ ・ ・ ・ Somewhat easy to crush △ ・ ・ ・ Slightly hard but crushed × ・ ・ ・ Hard and not crushable
<試験例4> カプセル体の硬度測定
カードメーターMAX(アイテクノエンジニアリング社製)を用いて、感圧軸11.3mmφ、荷重100gの条件で硬度を測定し、下記の4段階で評価した。結果を表1に示す。
評価条件;
◎・・・5〜15g
○・・・15〜20g
△・・・20〜25g
×・・・30g以上
<Test Example 4> Hardness measurement of capsule body Hardness was measured using a card meter MAX (manufactured by Eye Techno Engineering Co., Ltd.) under the conditions of a pressure-sensitive axis of 11.3 mmφ and a load of 100 g, and evaluated according to the following four grades. Table 1 shows the results.
Evaluation conditions;
◎ ・ ・ ・ 5-15g
○ ・ ・ ・ 15-20g
△ ・ ・ ・ 20-25g
× ・ ・ ・ 30g or more
本発明により、つぶしやすい硬さを備えながら、内相物の透過・放出を抑制でき、さら
につぶす際の感触が良好なカプセル体が提供されるため、本発明のカプセル体を化粧料に適用した場合の使用感や、食品に適用した場合の食感が優れたものとなる。また、本発明のカプセル体を化粧料に適用した場合に、内相に含有する有効成分の品質を維持したり、香りを長続きさせたりすることもできる。
According to the present invention, the capsule body of the present invention is applied to cosmetics, because the capsule body of the present invention is provided with a capsule body that can suppress the permeation and release of the internal phase substance and has a good feel when crushing while having hardness that is easy to crush. The feeling of use in the case and the texture when applied to food are excellent. Further, when the capsule body of the present invention is applied to cosmetics, the quality of the active ingredient contained in the internal phase can be maintained, and the fragrance can be maintained for a long time.
Claims (7)
前記カプセル外膜はアルギン酸カルシウム及び水溶性ポリマーを含み、
前記カプセル内相は油性成分を含み、
前記水溶性ポリマーがヒドロキシエチルセルロース、ポリビニルピロリドン及びアクリル酸系ポリマーから選択される一種又は二種以上を含み、
前記カプセル外膜と前記カプセル内相との質量比が3:7〜4:6である、カプセル体。 A capsule body comprising a capsule outer membrane and a capsule inner phase,
The capsule outer membrane includes calcium alginate and a water-soluble polymer,
The capsule inner phase contains an oily component,
The water-soluble polymer comprises one or more selected from hydroxyethyl cellulose, polyvinylpyrrolidone and acrylic acid-based polymer,
A capsule body, wherein the mass ratio between the capsule outer membrane and the capsule inner phase is 3: 7 to 4: 6 .
アルギン酸塩及び水溶性ポリマーを含む水溶液と、カルシウム塩を含む水溶液とを接触させる工程を含み、
前記水溶性ポリマーがヒドロキシエチルセルロース、ポリビニルピロリドン及びアクリル酸系ポリマーから選択される一種又は二種以上を含み、
前記アルギン酸塩及び水溶性ポリマーを含む水溶液におけるアルギン酸塩と水溶性ポリマーとの質量比が1:0.3〜1:1である、製造方法。 A method for producing a capsule body,
Contacting an aqueous solution containing an alginate and a water-soluble polymer with an aqueous solution containing a calcium salt,
The water-soluble polymer comprises one or more selected from hydroxyethyl cellulose, polyvinylpyrrolidone and acrylic acid-based polymer,
The production method, wherein the mass ratio of the alginate and the water-soluble polymer in the aqueous solution containing the alginate and the water-soluble polymer is 1: 0.3 to 1: 1 .
カルシウム塩を含む水溶液中に前記複合液滴を滴下することにより、アルギン酸塩及び水溶性ポリマーを含む水溶液と、カルシウム塩を含む水溶液とを接触させる工程を行う、請求項3に記載の製造方法。 The method further includes forming a composite droplet by covering the droplet of the solution containing the oily component with a liquid film of an aqueous solution containing alginate and a water-soluble polymer,
The production method according to claim 3 , wherein a step of contacting an aqueous solution containing alginate and a water-soluble polymer with an aqueous solution containing a calcium salt is performed by dropping the composite droplet into an aqueous solution containing a calcium salt.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014265121A JP6659075B2 (en) | 2014-12-26 | 2014-12-26 | Capsule body and method for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014265121A JP6659075B2 (en) | 2014-12-26 | 2014-12-26 | Capsule body and method for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016124801A JP2016124801A (en) | 2016-07-11 |
| JP6659075B2 true JP6659075B2 (en) | 2020-03-04 |
Family
ID=56358862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014265121A Active JP6659075B2 (en) | 2014-12-26 | 2014-12-26 | Capsule body and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6659075B2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3814021A2 (en) | 2018-06-29 | 2021-05-05 | The Procter & Gamble Company | Dual phase products dispenser |
| US11583479B2 (en) | 2018-06-29 | 2023-02-21 | The Procter & Gamble Company | Dual phase products |
| WO2020005787A2 (en) | 2018-06-29 | 2020-01-02 | The Procter & Gamble Company | Dual phase products |
| JP7160954B2 (en) | 2018-06-29 | 2022-10-25 | ザ プロクター アンド ギャンブル カンパニー | Two-phase product |
| WO2020221572A1 (en) * | 2019-04-30 | 2020-11-05 | Dsm Ip Assets B.V. | New delivery system for fat soluble vitamins |
| JP2021088542A (en) * | 2019-12-04 | 2021-06-10 | 雅子 加藤 | Granular shampoo and method for producing the same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63237747A (en) * | 1987-03-26 | 1988-10-04 | Sekisui Plastics Co Ltd | Fishing bait |
| KR920002279B1 (en) * | 1989-09-12 | 1992-03-21 | 태평양화학 주식회사 | Cosmetic capsule |
| KR930006431B1 (en) * | 1990-10-11 | 1993-07-16 | 재단법인 한국화학연구소 | Microcapsulation of drugs |
| JP3338715B2 (en) * | 1992-10-05 | 2002-10-28 | 株式会社コーセー | Capsule-containing cosmetics |
| JP2006174778A (en) * | 2004-12-24 | 2006-07-06 | Shin Etsu Chem Co Ltd | Method for producing oil-containing capsule |
| JP2007290997A (en) * | 2006-04-24 | 2007-11-08 | Kaneka Corp | Method and apparatus for producing granules included with liposoluble substance |
| JP2014114226A (en) * | 2012-12-07 | 2014-06-26 | Lion Corp | Microencapsulated pharmaceutical preparation, production method thereof and liquid internal agent |
| JP2016041671A (en) * | 2014-08-19 | 2016-03-31 | 三菱鉛筆株式会社 | Encapsulated cosmetic |
-
2014
- 2014-12-26 JP JP2014265121A patent/JP6659075B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016124801A (en) | 2016-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6659075B2 (en) | Capsule body and method for producing the same | |
| CN105899182B (en) | Composition comprising gelled capsules stabilized by a buffer | |
| US20150044263A1 (en) | Kit comprising two separate compositions, notably for cosmetic application | |
| KR20160016833A (en) | Fragrance-containing capsule and cosmetic in which said capsules are blended | |
| EA021290B1 (en) | Antiperspirant composition | |
| US8702016B2 (en) | Method and device for releasing a perfume or scent | |
| KR20170123698A (en) | Multi-layer cosmetic composition | |
| CN107080708A (en) | A kind of gentle multiple-effect face cleaning composition | |
| Mishra et al. | Formulation and evaluation of lipstick containing herbal ingredients | |
| JP5706889B2 (en) | Skin temperature raising agent | |
| US9554973B2 (en) | Micro-encapsulation of ozonated oils | |
| JP5851398B2 (en) | Sympathetic nerve inhibitor | |
| Bockmühl et al. | Prebiotic cosmetics: an alternative to antibacterial products | |
| US20120240408A1 (en) | Polyethylene glycol containing composition for shaving | |
| CN103961272B (en) | A kind of compounding skin care item based on white beeswax substrate and preparation method thereof | |
| US20170151364A1 (en) | Multi-component fragrance dispensing apparatus | |
| JP6097342B2 (en) | Sympathetic nerve activator, cosmetic for sympathetic nerve activation and food for sympathetic nerve activation containing the same | |
| JPH0881328A (en) | Cosmetic and / or dermatological composition containing a botanical compound for fixing a fragrance | |
| CN121127221A (en) | Perfuming cosmetic dispersions stabilized by sterile suspensions | |
| JP2017109955A (en) | Capsule body and manufacturing method thereof | |
| JP2021120366A (en) | Emulsified hydrogel particles and their manufacturing method | |
| JP7183022B2 (en) | granular composition | |
| JP2010235759A (en) | Oily solid perfume composition | |
| KR102241402B1 (en) | Production method for gel type cosmetic composition and cosmetic composition thereof | |
| JP5745805B2 (en) | Use of sedative effect imparting agent and sedative and 2R-teaspirane |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20171206 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180921 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181002 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181127 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190305 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190419 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190820 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191017 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200107 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200203 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6659075 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |